Clinical Trial Update: Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

View source ↗

Summary

Post-marketing surveillance study to assess safety and effectiveness of Rybelsus (oral semaglutide) in real-world Korean patients with Type 2 diabetes mellitus;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rybelsus (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Status: NOT_YET_RECRUITING